Roving Reporter Asks: Where Do You See the Most Progress in CGT Manufacturing and Scalability?
May 6, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to explore advances in scaling cell and gene therapies
False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
April 30, 2026
As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success
7 min read
April 29, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to unpack reactions to Takeda’s strategic shift.
April 28, 2026
FDA expands Tzield, EU clears Dupixent, and Health Canada approves denosumab antibody biosimilars
4 min read
April 28, 2026
From first conversations with regulators to global market strategy, early decisions shape speed, risk, and long-term success
3 min read
April 27, 2026
Lilly moves to acquire Kelonia, plus gene therapy for deafness approved
3 min read
April 24, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
4 min read
April 22, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to uncover the year’s defining breakthroughs
10 min read
April 21, 2026
Why temperature-controlled logistics is a critical but overlooked foundation of equitable access to medicines
4 min read
April 21, 2026
Revolution’s KRAS breakthrough, strong ADC signals from GSK, and shifting regulatory and dealmaking dynamics define this week in biopharma
3 min read
False